Oral Anticoagulant Therapy

Walter Ageno; Alexander Gallus; Ann K. Wittkowsky; Mark Crowther; Elaine M. Hylek; Gualtiero Palareti

doi:10.1378/chest.11-2292

Keywords

DabigatranRivaroxabanMedicineAnticoagulantDirect thrombin inhibitorAntithromboticIntensive care medicineDiscovery and development of direct thrombin inhibitorsPharmacodynamicsAdverse effectDrugIdarucizumabFondaparinuxPharmacologyPharmacokineticsWarfarinThrombosisSurgeryThrombinInternal medicineAtrial fibrillationVenous thromboembolism

Affiliated Institutions

Related Publications

Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects

Dagmar Kubitza , Michael Becka , Angelika Roth +1 more

Each single dose of rivaroxaban was well tolerated, with predictable pharmacokinetics and pharmacodynamics at doses up to 40 mg, and provided effective anticoagulation in health...

2008 Current Medical Research and Opinion 270 citations

Atrial fibrillation and stroke prevention

Gregory Y.H. Lip , Hoong Sern Lim

2007 The Lancet Neurology 235 citations

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

Annie Young , Andrea Marshall , Jenny Thirlwall +15 more

Purpose Venous thromboembolism (VTE) is common in patients with cancer. Long-term daily subcutaneous low molecular weight heparin has been standard treatment for such patients. ...

2018 Journal of Clinical Oncology 1241 citations

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty

Bengt I. Eriksson , Lars C. Borris , Richard J. Friedman +8 more

A once-daily, 10-mg oral dose of rivaroxaban was significantly more effective for extended thromboprophylaxis than a once-daily, 40-mg subcutaneous dose of enoxaparin in patient...

2008 New England Journal of Medicine 1419 citations

Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis

Giancarlo Agnelli , Paolo Prandoni , Maria Gabriella Santamaria +26 more

In patients with idiopathic deep venous thrombosis, the clinical benefit associated with extending the duration of anticoagulant therapy to one year is not maintained after the ...

2001 New England Journal of Medicine 588 citations

Publication Info

Year: 2012
Type: review
Volume: 141
Issue: 2
Pages: e44S-e88S
Citations: 1471
Access: Closed

External Links

Download PDF (Free) View on DOI.org PubMed Semantic Scholar

Social Impact

Altmetric

Oral Anticoagulant Therapy

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1471

OpenAlex

Influential

1206

CrossRef

Cite This

APA Style

                            
                                
                                    Walter Ageno, 
                                
                                    Alexander Gallus, 
                                
                                    Ann K. Wittkowsky
                                
                                et al.
                            
                            (2012). 
                            Oral Anticoagulant Therapy. 
                            CHEST Journal
                            , 141
                            (2)
                            , e44S-e88S.
                            https://doi.org/10.1378/chest.11-2292
                        

Identifiers

DOI: 10.1378/chest.11-2292
PMID: 22315269

Data Quality

Data completeness: 68%